相关实验视频

Updated: Jan 14, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

新抗原鉴定和固体瘤的TCR-T疗法开发:目前的进展和未来的前景

Xinyao Zheng¹, Yahui Zhao¹, Zhihua Liu¹

¹State Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Journal of the National Cancer Center

|October 20, 2025

概括

工程T细胞受体T细胞 (TCR-T) 显示出对固体瘤的承诺. 向新抗原,独特的瘤标记物,提供比传统的瘤相关抗原更大的特异性和安全性,推进个性化癌症治疗.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
生物技术是生物技术.

背景情况:

工程T细胞受体T细胞 (TCR-T) 由于选择性瘤细胞杀死和高安全性,是固体瘤的有前途的癌症治疗方法.
目前的TCR-T疗法通常向与瘤相关的抗原,这可能导致非向效应和患者异质性问题.
由瘤特异性基因组变化产生的新抗原提供了更高的特异性,并代表了一种有价值的治疗标.

研究的目的:

审查抗原分类,重点关注TCR-T疗法的新抗原.
探索识别和验证新抗原的策略.
评估针对新抗原的TCR-T的治疗有效性,并讨论挑战和解决方案.

主要方法:

对抗原分类和向策略的文献综述.
对TCR-T和其他针对新抗原的免疫疗法的研究分析.
讨论TCR-T治疗中的挑战和潜在解决方案.

主要成果:

与瘤相关抗原相比,新抗原为TCR-T疗法提供了更具体的点.
对新抗原的识别和验证策略对于治疗开发至关重要.
针对新抗原的TCR-T疗法显示出潜力,但面临挑战.

结论:

用TCR-T细胞向新抗原是精确癌症医学的一个有希望的方向.
需要进一步研究新抗原的识别,验证和克服治疗挑战.
这种方法有可能开发出更有效和个性化的癌症治疗方法.

关键词:

在CART-T中,我们可以使用CAR-T.免疫治疗是一种免疫疗法.新抗原是一种新抗原.这就是TCR-T.

更多相关视频

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...